Italy Cell and Gene Therapy Manufacturing QC Market Size & Outlook, 2025-2028
Italy Cell and Gene Therapy Manufacturing QC Market Size
According to Straits Research analysis, the Italy Cell and Gene Therapy Manufacturing QC Market was valued at USD 36.64 Million in 2024 and is projected to reach USD 96.8 Million by 2028, expanding at a CAGR of 27.6% during the forecast period. The primary drivers for this growth are rooted in biopharmaceutical industries, increased adoption of personalized medicine and steady drug development. Agriculture and the energy sectors are also embracing cell and gene therapy for increased productivity and sustainability. Technological advancements in gene editing tools like CRISPR are creating significant opportunities. Robust export potential, brought about by stringent quality control standards, further fuels expansion. Italy is poised to leverage these trends, positioning itself for noteworthy growth in the global cell and gene therapy manufacturing QC market.
Source: Straits Research Analysis Company Publications, Primary Interviews.
Italy Cell and Gene Therapy Manufacturing QC Market Highlights
- In 2024, Cell Therapy accounted for the highest share of the Therapy Type market size.
- During the forecast period, Gene Therapy is set to register the highest growth, making it the most lucrative Therapy Type segment.
- In 2024, Italy represented 1.64% of the overall global cell and gene therapy manufacturing qc market size.
- United States is projected to lead the global cell and gene therapy manufacturing qc market size by 2028.
- Across Europe, Germany is anticipated to hold the dominant position in market by 2028.
- France is forecasted to expand at the fastest pace in Europe, attaining USD 45534 Million by 2028.
- 📊 Preview Report Scope and Structure – Gain immediate visibility into key topics, market segments, and data frameworks covered.
- 📥 Evaluate Strategic Insights – Access selected charts, statistics, and analyst-driven commentary derived from the final report deliverables.
Report Summary
| Report Scope | Details |
|---|---|
| Base Year for Study | 2024 |
| Study Period | 2021-2028 |
| Historical Period | 2021-2023 |
| Forecast Period | 2025-2028 |
| Market Size In 2024 | USD 36.64 Million |
| Market Size In 2028 | USD 96.8 Million |
| Largest segment | Cell Therapy |
| Fastest segment | Gene Therapy |
| Units | Revenue in USD Million |
| CAGR | 27.6% (2025-2028) |
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends |
Italy Cell and Gene Therapy Manufacturing QC Market Share By Therapy Type
Segmentation Covered
| Segments | Sub Segments |
|---|---|
| Therapy Type |
|
| Cell Therapy |
|
| CAR-T |
|
| Gene Therapy |
|
| Viral |
|
| Scale |
|
| Mode |
|
| Workflow |
|
| Process |
|
| End User |
|
| Pharmaceutical Companies |
|
| Biopharmaceutical / Biotechnological Companies |
|
| Contract Manufacturing Organizations |
|
| Technology Type |
|
Italy Cell and Gene Therapy Manufacturing QC Market By Therapy Type 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
Italy Cell and Gene Therapy Manufacturing QC Market By Cell Therapy 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
Italy Cell and Gene Therapy Manufacturing QC Market By CAR-T 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
Italy Cell and Gene Therapy Manufacturing QC Market By Gene Therapy 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
Italy Cell and Gene Therapy Manufacturing QC Market By Viral 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
Italy Cell and Gene Therapy Manufacturing QC Market By Scale 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
Italy Cell and Gene Therapy Manufacturing QC Market By Mode 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
Italy Cell and Gene Therapy Manufacturing QC Market By Workflow 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
Italy Cell and Gene Therapy Manufacturing QC Market By Process 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
Italy Cell and Gene Therapy Manufacturing QC Market By End User 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
Italy Cell and Gene Therapy Manufacturing QC Market By Pharmaceutical Companies 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
Italy Cell and Gene Therapy Manufacturing QC Market By Biopharmaceutical / Biotechnological Companies 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
Italy Cell and Gene Therapy Manufacturing QC Market By Contract Manufacturing Organizations 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
Italy Cell and Gene Therapy Manufacturing QC Market By Technology Type 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
